CN Patent

CN102885759A — 利塞膦酸钠延释制剂及其制备方法

Assigned to HAINAN PULIN PHARMACEUTICAL CO Ltd · Expires 2013-01-23 · 13y expired

What this patent protects

本发明涉及利塞膦酸钠延释制剂及其制备方法。所述的利塞膦酸钠延释制剂，包括5%~30%利塞膦酸钠、10%~60%螯合剂、1%~20%延释材料以及10%~70%其他制剂辅料。本发明利塞膦酸钠延释制剂，一周只需服用一次就可以获得较好的治疗效果，有效减少服药次数，提高了患者的顺应性。

USPTO Abstract

本发明涉及利塞膦酸钠延释制剂及其制备方法。所述的利塞膦酸钠延释制剂，包括5%~30%利塞膦酸钠、10%~60%螯合剂、1%~20%延释材料以及10%~70%其他制剂辅料。本发明利塞膦酸钠延释制剂，一周只需服用一次就可以获得较好的治疗效果，有效减少服药次数，提高了患者的顺应性。

Drugs covered by this patent

Patent Metadata

Patent number
CN102885759A
Jurisdiction
CN
Classification
—
Expires
2013-01-23
Drug substance claim
No
Drug product claim
No
Assignee
HAINAN PULIN PHARMACEUTICAL CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.